A New Pill Can Potentially Treat Bleeding From Uterine Fibroids
Recently, AbbVie, a pharmaceutical company that develops new drugs and treatments, issued an application for approval in the U.S. Food and Drug Administration for its newly developed drug known as Elagolix for managing complications caused by uterine fibroids. Uterine fibroids, also commonly referred to as uterine myoma or leiomyomas, are noncancerous tumors that develop inside…